Yoon notes the following as attractive invesment opportunities:
– Biotech drug innovation
– Global demographic trends
– Effective capital allocation
– New IT enhancements
– Pharmacueticals
– Medical Equipment Stocks
Some risks Yoon notes on these investments are the uncertainity surrounding U.S. health care reform and drug pricing and reimbursement pressure.
To read the report in full, click here.
To learn more about Fidelity Investments, click here.
